GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates - Prime Therapeutics
In the News
GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates
BioSpace: While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
Latest News
Login Portals
Compliance / Legal
Careers
© 2025 Prime Therapeutics LLC